Bimatoprost
C25H37NO4
415.57
5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl]-N-ethyl-, {1R-1[α(Z),2β(1E,3S*)3α,5α]}-;
(Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide [155206-00-1]
5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl]-N-ethyl-, {1R-1[α(Z),2β(1E,3S*)3α,5α]}-;
(Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide [155206-00-1]
DEFINITION
Bimatoprost contains NLT 97.5% and NMT 101.0% of bimatoprost (C25H37NO4), calculated on the anhydrous and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Bimatoprost RSUSP Bimatoprost Related Compound A RS
USP Orlistat Related Compound C RS